可以依据的香港本土法规有以下几种：

• 36B of the Pharmacy and Poison Regulations

• Clinical Trial / Medicinal Test - Application Guidelines and Forms

• Guidance for Pharmaceutical Industry - Adverse Drug Reaction Reporting Requirements (NOV 2017)

• Import and Export of Pharmaceutical Products

如果该临床试验的结果用于中国递交，需要同时遵从中国NMPA GCP药品管理的相关规定。

https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/guidelines_forms/useful_guidelines_forms.html供参考。申办者需要具备获取相应法规的能力。